A homozygous nonsense mutation in SOX9 in the dominant disorder campomelic dysplasia : a case of mitotic gene conversion

• Published in: Human genetics Vol. 117; no. 1; pp. 43 - 53
• Main Authors: POP, Ramona, ZARAGOZA, Michael V, GAUDETTE, Mara, DOHRMANN, Ulrike, SCHERER, Gerd
• Format: Journal Article
• Language: English
• Published: Heidelberg Springer 01.06.2005; Berlin Springer Nature B.V; New York, NY
• Subjects: Abnormalities, Multiple; Biological and medical sciences; Bone Diseases, Developmental - genetics; Chromosomes, Human, Pair 17; Classical genetics, quantitative genetics, hybrids; Codon, Nonsense; Diseases of the osteoarticular system; Disorders of Sex Development; Dysplasia; Fatal Outcome; Female; Fundamental and applied biological sciences. Psychology; Gene Conversion; Gene mutations; Genes; Genetic aspects; Genetics of eukaryotes. Biological and molecular evolution; High Mobility Group Proteins - genetics; Human; Humans; Infant, Newborn; Inheritance Patterns; Karyotyping; Malformations and congenital and or hereditary diseases involving bones. Joint deformations; Medical sciences; Microsatellite Repeats; Mitosis; Mosaicism; Polymorphism, Single Nucleotide; Sex Chromosome Aberrations; Sex Differentiation; Single nucleotide polymorphisms; SOX9 Transcription Factor; Transcription Factors - genetics; Nonsense mutation; Diseases of the osteoarticular system; Campomelic dysplasia; Genetics; Gene conversion; Osteochondrodysplasia; Genetic disease
• ISSN: 0340-6717; 1432-1203
• DOI: 10.1007/s00439-005-1295-y

Campomelic dysplasia (CD; MIM 114290), an autosomal dominant skeletal malformation syndrome with XY sex reversal, is caused by heterozygous de novo mutations in and around the SOX9 gene on 17q. We report a patient with typical signs of CD, including sex reversal, who was, surprisingly, homozygous for the nonsense mutation Y440X. Since neither parent carried the Y440X mutation, possible mechanisms explaining the homozygous situation were a de novo mutation followed by uniparental isodisomy, somatic crossing over, or gene conversion. As the patient was heterozygous for six microsatellite markers flanking SOX9, uniparental isodisomy and somatic crossing over were excluded. Analysis of intragenic single-nucleotide polymorphisms suggested that the homozygous mutation arose by a mitotic gene conversion event involving exchange of at least 440 nucleotides and at most 2,208 nucleotides between a de novo mutant maternal allele and a wild-type paternal allele. Analysis of cloned alleles showed that homozygous mutant cells constituted about 80% of the leukocyte cell population of the patient, whereas about 20% were heterozygous mutant cells. Heterozygous Y440X mutations, previously described in three CD cases, have been identified in seven additional cases, thus constituting the most frequent recurrent mutations in SOX9. These patients frequently have a milder phenotype with longer survival, possibly because of the retention of some transactivation activity of the mutant protein on SOX9 target genes, as shown by cell transfection experiments. The fact that the patient survived for 3 months may thus be explained by homozygosity for a hypomorphic rather than a complete loss-of-function allele, in combination with somatic mosaicism. This is, to our knowledge, the first report of mitotic gene conversion of a wild-type allele by a de novo mutant allele in humans.